|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 304,400.00 COP | 0.00% |
|
+1.47% | +7.94% |
| 12/03 | Grupo Nutresa S. A., Q4 2025 Earnings Call, Feb 19, 2026 | |
| 19/02 | Grupo Nutresa S. A. Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.1 | 4.82 | 5.96 | 6.99 | 6.7 | |||||
Return on Total Capital | 5.18 | 6.18 | 7.82 | 9.4 | 8.4 | |||||
Return On Equity % | 8.38 | 9.11 | 8.58 | 11.29 | 21.66 | |||||
Return on Common Equity | 8.25 | 8.97 | 8.43 | 11.21 | 21.72 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 38.45 | 35.12 | 37.27 | 39.19 | 39.46 | |||||
SG&A Margin | 30.09 | 26.69 | 28.24 | 29.29 | 28.09 | |||||
EBITDA Margin % | 10.55 | 10.31 | 11.53 | 11.58 | 12.98 | |||||
EBITA Margin % | 8.45 | 8.6 | 9.99 | 10.08 | 11.52 | |||||
EBIT Margin % | 8.36 | 8.53 | 9.19 | 9.82 | 11.56 | |||||
Income From Continuing Operations Margin % | 5.69 | 5.3 | 3.91 | 4.12 | 6.6 | |||||
Net Income Margin % | 5.31 | 5.18 | 3.81 | 4.04 | 6 | |||||
Net Avail. For Common Margin % | 5.56 | 5.18 | 3.81 | 4.04 | 6.55 | |||||
Normalized Net Income Margin | 4.68 | 4.49 | 3.2 | 3.9 | 4.91 | |||||
Levered Free Cash Flow Margin | 2.66 | -2.59 | 7.76 | 1.47 | 4.22 | |||||
Unlevered Free Cash Flow Margin | 3.26 | -1.27 | 9.98 | 3.56 | 8.54 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.78 | 0.9 | 1.04 | 1.14 | 0.93 | |||||
Fixed Assets Turnover | 2.93 | 3.63 | 3.84 | 3.63 | 3.89 | |||||
Receivables Turnover (Average Receivables) | 9.9 | 10.52 | 10.62 | 9.73 | 9.74 | |||||
Inventory Turnover (Average Inventory) | 4.56 | 4.25 | 4.14 | 4.44 | 4.64 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.75 | 1.79 | 1.56 | 1.73 | 1.97 | |||||
Quick Ratio | 0.95 | 0.87 | 0.87 | 1 | 1.34 | |||||
Operating Cash Flow to Current Liabilities | 0.41 | 0.14 | 0.57 | 0.48 | 0.54 | |||||
Days Sales Outstanding (Average Receivables) | 36.88 | 34.7 | 34.37 | 37.63 | 37.48 | |||||
Days Outstanding Inventory (Average Inventory) | 80.11 | 85.82 | 88.07 | 82.4 | 78.64 | |||||
Average Days Payable Outstanding | 40.22 | 37.25 | 39.6 | 34.1 | 36.67 | |||||
Cash Conversion Cycle (Average Days) | 76.78 | 83.26 | 82.84 | 85.93 | 79.45 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 46.09 | 49.7 | 79.88 | 77.91 | 319.56 | |||||
Total Debt / Total Capital | 31.55 | 33.2 | 44.41 | 43.79 | 76.17 | |||||
LT Debt/Equity | 42.93 | 43.21 | 65.21 | 66.9 | 299.84 | |||||
Long-Term Debt / Total Capital | 29.39 | 28.87 | 36.25 | 37.6 | 71.47 | |||||
Total Liabilities / Total Assets | 46.67 | 47.95 | 58.92 | 57.98 | 80.24 | |||||
EBIT / Interest Expense | 8.67 | 4.04 | 2.58 | 2.93 | 1.67 | |||||
EBITDA / Interest Expense | 11.98 | 5.27 | 3.45 | 3.71 | 1.99 | |||||
(EBITDA - Capex) / Interest Expense | 8.64 | 4.03 | 2.71 | 2.76 | 1.73 | |||||
Total Debt / EBITDA | 2.83 | 2.83 | 2.22 | 2.4 | 6.09 | |||||
Net Debt / EBITDA | 2.23 | 2.21 | 1.72 | 1.88 | 4.93 | |||||
Total Debt / (EBITDA - Capex) | 3.92 | 3.71 | 2.82 | 3.23 | 7.02 | |||||
Net Debt / (EBITDA - Capex) | 3.08 | 2.89 | 2.19 | 2.53 | 5.68 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 14.48 | 33.75 | 10.97 | -1.67 | 10.7 | |||||
Gross Profit, 1 Yr. Growth % | 9.97 | 22.17 | 17.75 | 3.4 | 11.47 | |||||
EBITDA, 1 Yr. Growth % | 6.11 | 30.73 | 24.18 | 5.3 | 23.37 | |||||
EBITA, 1 Yr. Growth % | 8.18 | 36.16 | 28.79 | 6.89 | 25.66 | |||||
EBIT, 1 Yr. Growth % | 8.86 | 36.42 | 19.59 | 5 | 29.36 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 23.97 | 24.75 | -18.17 | 3.48 | 77.39 | |||||
Net Income, 1 Yr. Growth % | 17.63 | 30.45 | -18.4 | 4.27 | 64.49 | |||||
Normalized Net Income, 1 Yr. Growth % | 20.71 | 28.48 | -20.89 | 19.38 | 39.88 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 23.25 | 25.03 | -18.41 | 4.27 | 79.86 | |||||
Accounts Receivable, 1 Yr. Growth % | 16.02 | 34.29 | -8.24 | 24.34 | -0.49 | |||||
Inventory, 1 Yr. Growth % | 28.31 | 68.71 | -24.62 | 6.9 | 4.1 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 4.14 | 11.36 | -0.83 | 9.15 | -2.5 | |||||
Total Assets, 1 Yr. Growth % | 9.13 | 22.42 | -24.42 | 7.99 | 61.84 | |||||
Tangible Book Value, 1 Yr. Growth % | 14.16 | 25.05 | -59.26 | 20.9 | -46.5 | |||||
Common Equity, 1 Yr. Growth % | 9.37 | 19.52 | -40.58 | 10.5 | -23.57 | |||||
Cash From Operations, 1 Yr. Growth % | -8.53 | -50.9 | 295.84 | -16.28 | 36.63 | |||||
Capital Expenditures, 1 Yr. Growth % | 37.15 | 9.04 | 11.26 | 18.97 | -30.54 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -45.32 | -245.45 | -432.08 | -78.79 | 208.62 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -42.76 | -152.14 | -970.78 | -61.24 | 162.42 | |||||
Dividend Per Share, 1 Yr. Growth % | 35.04 | 22.09 | - | - | - | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 13.1 | 23.74 | 21.83 | 4.46 | 4.33 | |||||
Gross Profit, 2 Yr. CAGR % | 7.59 | 15.91 | 19.94 | 10.34 | 7.36 | |||||
EBITDA, 2 Yr. CAGR % | 7.04 | 17.78 | 27.41 | 10.69 | 14.34 | |||||
EBITA, 2 Yr. CAGR % | 8.58 | 21.37 | 32.42 | 13.03 | 16.32 | |||||
EBIT, 2 Yr. CAGR % | 8.32 | 21.86 | 27.73 | 12.06 | 16.99 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 17.24 | 24.36 | 1.04 | -7.98 | 35.49 | |||||
Net Income, 2 Yr. CAGR % | 15.94 | 23.87 | 3.17 | -7.76 | 30.97 | |||||
Normalized Net Income, 2 Yr. CAGR % | 15.28 | 24.53 | 0.82 | -2.67 | 28.94 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 16.84 | 24.13 | 1 | -7.76 | 36.95 | |||||
Accounts Receivable, 2 Yr. CAGR % | 8.88 | 24.82 | 11.01 | 6.82 | 11.23 | |||||
Inventory, 2 Yr. CAGR % | 19.94 | 47.13 | 12.77 | -10.23 | 5.49 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 1.67 | 7.69 | 5.09 | 4.04 | 3.16 | |||||
Total Assets, 2 Yr. CAGR % | 4.06 | 15.58 | -3.81 | -9.66 | 32.2 | |||||
Tangible Book Value, 2 Yr. CAGR % | 0.8 | 19.48 | -28.63 | -29.82 | -19.58 | |||||
Common Equity, 2 Yr. CAGR % | 1.96 | 14.33 | -15.73 | -18.97 | -8.1 | |||||
Cash From Operations, 2 Yr. CAGR % | 2.93 | -32.98 | 39.41 | 82.04 | 6.95 | |||||
Capital Expenditures, 2 Yr. CAGR % | 18.34 | 22.29 | 10.15 | 15.05 | -13.13 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -9.77 | -15.58 | 119.77 | -21.42 | -17.84 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -11.44 | -45.37 | 113.09 | 74.7 | 1.5 | |||||
Dividend Per Share, 2 Yr. CAGR % | 20.84 | 28.4 | - | - | - | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 12.21 | 19.6 | 19.33 | 13.43 | 6.5 | |||||
Gross Profit, 3 Yr. CAGR % | 7.89 | 12.25 | 16.52 | 14.15 | 10.72 | |||||
EBITDA, 3 Yr. CAGR % | 6.74 | 14.42 | 19.88 | 17.01 | 15.01 | |||||
EBITA, 3 Yr. CAGR % | 8.65 | 17.09 | 23.79 | 20.27 | 17.38 | |||||
EBIT, 3 Yr. CAGR % | 8.91 | 16.98 | 21.1 | 19.65 | 17.85 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 12.06 | 19.7 | 8.17 | 1.85 | 14.53 | |||||
Net Income, 3 Yr. CAGR % | 10.23 | 20.59 | 7.78 | 3.54 | 11.86 | |||||
Normalized Net Income, 3 Yr. CAGR % | 11.68 | 19.53 | 7.05 | 6.77 | 9.68 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 11.55 | 19.51 | 7.93 | 2.08 | 15.24 | |||||
Accounts Receivable, 3 Yr. CAGR % | 10.65 | 16.77 | 12.66 | 15.29 | 4.32 | |||||
Inventory, 3 Yr. CAGR % | 17.11 | 34.39 | 17.73 | 10.78 | -5.69 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 9.56 | 4.8 | 4.77 | 6.42 | 1.81 | |||||
Total Assets, 3 Yr. CAGR % | 7.83 | 9.85 | 0.32 | -0.03 | 9.72 | |||||
Tangible Book Value, 3 Yr. CAGR % | 0.84 | 8.31 | -16.53 | -14.92 | -35.89 | |||||
Common Equity, 3 Yr. CAGR % | 2.65 | 7.51 | -8.08 | -7.76 | -20.53 | |||||
Cash From Operations, 3 Yr. CAGR % | 8.8 | -19.58 | 21.14 | 17.62 | 65.44 | |||||
Capital Expenditures, 3 Yr. CAGR % | 17.42 | 15.16 | 18.5 | 13.01 | -5.66 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 1.74 | 1.99 | 33.26 | -3.52 | 25.26 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -2.3 | -25.77 | 37.49 | 16.75 | 100.94 | |||||
Dividend Per Share, 3 Yr. CAGR % | 15.7 | 21.26 | - | - | - | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 7.98 | 14.4 | 15.96 | 13.3 | 13.08 | |||||
Gross Profit, 5 Yr. CAGR % | 6.57 | 10.08 | 12.56 | 11.48 | 12.77 | |||||
EBITDA, 5 Yr. CAGR % | 6.14 | 12.03 | 14.57 | 12.91 | 16.11 | |||||
EBITA, 5 Yr. CAGR % | 6.68 | 14.55 | 17.6 | 15.45 | 18.96 | |||||
EBIT, 5 Yr. CAGR % | 6.58 | 14.79 | 16.08 | 14.98 | 19.44 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 12.53 | 16.27 | 7.51 | 7.75 | 18.36 | |||||
Net Income, 5 Yr. CAGR % | 11.33 | 16.01 | 7.35 | 8.33 | 16.52 | |||||
Normalized Net Income, 5 Yr. CAGR % | 13.68 | 19.37 | 7.2 | 10.1 | 15.39 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 12.29 | 16.07 | 7.2 | 7.75 | 18.72 | |||||
Accounts Receivable, 5 Yr. CAGR % | 9.23 | 14.16 | 10.79 | 12.68 | 12.08 | |||||
Inventory, 5 Yr. CAGR % | 11.87 | 25.12 | 15.36 | 14.36 | 12.67 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 5.54 | 7.81 | 7.75 | 4.49 | 4.12 | |||||
Total Assets, 5 Yr. CAGR % | 4.36 | 7.72 | 3.01 | 1.59 | 12.03 | |||||
Tangible Book Value, 5 Yr. CAGR % | 0.06 | 2.86 | -12.18 | -8.95 | -17.76 | |||||
Common Equity, 5 Yr. CAGR % | 1.44 | 3.77 | -5.14 | -3.99 | -8.09 | |||||
Cash From Operations, 5 Yr. CAGR % | 6.06 | -11.12 | 20.15 | 11.51 | 15.25 | |||||
Capital Expenditures, 5 Yr. CAGR % | -0.08 | 11.61 | 14.45 | 15.11 | 4.66 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 22.69 | -3.94 | 35.44 | -8.11 | 6.97 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 7.15 | -20.67 | 33.46 | 4.53 | 19.35 | |||||
Dividend Per Share, 5 Yr. CAGR % | 12.16 | 15.36 | - | - | - |
- Stock Market
- Equities
- NUTRESA Stock
- Financials Grupo Nutresa S. A.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















